IRIS - Res&Arch Institutional Research Information System - Research & Archive

CAMILLONI, Barbara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.100
AS - Asia 3.369
EU - Europa 2.766
SA - Sud America 558
AF - Africa 71
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 4
Totale 10.876
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.973
SG - Singapore 1.481
IE - Irlanda 523
VN - Vietnam 467
HK - Hong Kong 458
BR - Brasile 437
UA - Ucraina 437
CN - Cina 420
RU - Federazione Russa 402
IT - Italia 366
DE - Germania 251
FR - Francia 185
FI - Finlandia 183
KR - Corea 120
SE - Svezia 117
GB - Regno Unito 99
BD - Bangladesh 92
IN - India 75
CA - Canada 64
TR - Turchia 55
AR - Argentina 40
MX - Messico 39
AT - Austria 33
PK - Pakistan 27
PL - Polonia 27
NL - Olanda 24
BE - Belgio 23
EC - Ecuador 22
IQ - Iraq 21
ID - Indonesia 20
CH - Svizzera 19
SA - Arabia Saudita 19
JP - Giappone 17
UZ - Uzbekistan 16
ZA - Sudafrica 15
CO - Colombia 14
ES - Italia 13
LB - Libano 13
MA - Marocco 13
PH - Filippine 13
PT - Portogallo 13
CZ - Repubblica Ceca 11
VE - Venezuela 11
CL - Cile 10
PY - Paraguay 10
LT - Lituania 9
GR - Grecia 7
AU - Australia 6
AZ - Azerbaigian 6
KE - Kenya 6
MY - Malesia 6
OM - Oman 6
TN - Tunisia 6
BG - Bulgaria 5
BO - Bolivia 5
CR - Costa Rica 5
EG - Egitto 5
JO - Giordania 5
PE - Perù 5
RO - Romania 5
DO - Repubblica Dominicana 4
DZ - Algeria 4
GH - Ghana 4
IL - Israele 4
NP - Nepal 4
TH - Thailandia 4
EU - Europa 3
HN - Honduras 3
PS - Palestinian Territory 3
RS - Serbia 3
UY - Uruguay 3
AL - Albania 2
AO - Angola 2
BH - Bahrain 2
BY - Bielorussia 2
CG - Congo 2
CI - Costa d'Avorio 2
ET - Etiopia 2
KH - Cambogia 2
NZ - Nuova Zelanda 2
PA - Panama 2
AE - Emirati Arabi Uniti 1
AG - Antigua e Barbuda 1
AM - Armenia 1
BB - Barbados 1
BN - Brunei Darussalam 1
CU - Cuba 1
DK - Danimarca 1
EE - Estonia 1
GD - Grenada 1
GE - Georgia 1
GF - Guiana Francese 1
GN - Guinea 1
GP - Guadalupe 1
GT - Guatemala 1
HU - Ungheria 1
IR - Iran 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 10.853
Salva come PNG Salva come JPEG
Città #
Singapore 1.097
Chandler 541
Dublin 522
Hong Kong 457
San Jose 432
Dong Ket 290
Ashburn 287
Jacksonville 240
San Mateo 240
Boardman 166
Santa Clara 161
Moscow 158
Lauterbourg 124
Medford 115
Princeton 115
Munich 108
Beijing 107
Seoul 104
Perugia 101
Wilmington 82
Ho Chi Minh City 74
Andover 73
Ann Arbor 72
Los Angeles 68
New York 64
Helsinki 56
São Paulo 45
Altamura 38
Piscataway 36
Izmir 33
Lawrence 32
Orem 32
Turku 31
Columbus 30
The Dalles 29
Saint Petersburg 28
Rome 27
Hanoi 26
Des Moines 25
Genoa 23
London 23
Brooklyn 22
Falls Church 21
Norwalk 21
Nuremberg 21
Ottawa 20
Montreal 19
Vienna 19
Frankfurt am Main 18
Redwood City 18
Warsaw 18
Houston 17
Redmond 17
Chennai 16
Amsterdam 15
Boston 14
Denver 14
Dongjak-gu 14
Tokyo 14
Brussels 13
Chicago 13
Dallas 13
Mexico City 13
Johannesburg 12
Florence 11
Hefei 11
Mumbai 11
Rio de Janeiro 11
Milan 10
Stockholm 10
Terni 10
Ankara 9
Belo Horizonte 9
Curitiba 9
Da Nang 9
Manchester 9
Shanghai 9
Toronto 9
Woodbridge 9
Council Bluffs 8
Haiphong 8
Jakarta 8
San Francisco 8
Seattle 8
Atlanta 7
Baghdad 7
Buffalo 7
Falconara Marittima 7
Guarulhos 7
Karachi 7
Phoenix 7
Porto 7
Porto Alegre 7
Baku 6
Campinas 6
Corciano 6
Den Haag 6
Dhaka 6
Duque de Caxias 6
Düsseldorf 6
Totale 6.985
Salva come PNG Salva come JPEG
Nome #
10-Year Rotavirus Infection Surveillance: Epidemiological Trends in the Pediatric Population of Perugia Province 207
Antibody response and protection after intradermal and intramuscular 2011/2012 trivalent influenza vaccination in elderly volunteers 144
Anti-Biofilm Properties of Saccharomyces cerevisiae CNCM I-3856 and Lacticaseibacillus rhamnosus ATCC 53103 Probiotics against G. vaginalis 142
Antibodies cross-reactive to seasonal influenza A(H1N1)pdm09 viruses in human sera of elderly people immunized with trivalent influenza vaccines containing the A/California/7/09 vaccine strain 135
Accelerate Pheno™ blood culture detection system: a literature review 132
Absence of Interaction Between Influenza Vaccination and Oral Anticoagulant Therapy: A Randomized Blinded Clinical Trial 128
Antibody Responses after Influenza Vaccination in Elderly People: Useful Information from a 27-Year Study (from 1988–1989 to 2014–2015) 125
Influenza vaccination in patients on long-term anticoagulant therapy. 123
Influenza vaccination in patients on long-term anticoagulant therapy 123
Is recurrence possible in coronavirus disease 2019 (COVID-19)? Case series and systematic review of literature 120
Interaction Between Influenza Vaccination and Oral Anticoagulant Therapy: A Randomized Blinded Clinical Trial. 119
An influenza A/H3 outbreak during the 2004/2005 winter in elderlyvaccinated people living in a nursing home 118
Antibody responses and HIV-1 viral load in HIV-1-seropositive subjects immunised with either the MF59 adjuvanted influenza vaccine or a conventional non-adjuvanted subunit vaccine during highly active antiretroviral therapy. 117
Molecular analysis of Group of Rotaviruses detected in subjects with severe acute gastroenteritis in Umbria from 2006 to 2012 117
Search for SARS-CoV-2 RNA in platelets from COVID-19 patients 117
Annually repeated influenza vaccination and humoral response in elderly volunteers. 115
Effects of probiotic administration on immune responses of children and adolescents with type 1 diabetes to a quadrivalent inactivated influenza vaccine 115
Immunogenicity of the MF-59-adjuvanted influenza vaccine in volunteers of different groups of age. 111
An influenza A/H3 outbreak during the 2004/05 winter in elderly vaccinated people living in a nursing home. 110
An influenza B outbreak during the 2007/2008 winter among appropriately immunized elderly people living in a nursing home. 110
An observational retrospective study provide information on hospitalization and severe outcomes of the 2009 A(H1N1) infection in Italy. 110
A novel methodology based on serological data for improving precision in the influenza vaccine response of non-seroprotected 110
Antibody response elicited by 2012/2013 “implemented influenza vaccines”, FLUAD® (Novartis Vaccines & Diagnostics) and INTANZA® 15Mcg (Sanofi Pasteur MSD), in chronically ill institutionalized elderly volunteers 108
Antibody response against unchanged influenza vaccine components in elderly people vaccinated in consecutive years 107
Influenza vaccine immunogenicity and efficacy in istitutionalized elderly volunteers (winter season 2002/03). 105
Clinical characteristics of influenza A/H1N1, A/H3N2 and B infections in children during three consecutive winter seasons (2012-13, 2013-14 and 2014-15) 104
Accuracy and impact on patient management of new tools for diagnosis of sepsis: Experience with the t2 magnetic resonance bacteria panel 104
Differente risposta anticorpale al vaccine anti-influenzale per l’inverno 2008/2009 in soggetti anziani residenti in due differenti case di riposo. 103
A G12P[8] rotavirus gastroenteritis outbreak in Italy, 2013 103
Cross-reactive antibodies in middle-aged and elderly volunteers after MF59-adjuvanted subunit trivalent influenza vaccine against B viruses of the B/Victoria or B/Yamagata lineages 101
Antibody responses to intradermal or intramuscular MF59-adjuvanted influenza vaccines as evaluated in elderly institutionalized volunteers during a season of partial mismatching between vaccine and circulatingA(H3N2)strains 101
Induzione di risposta immunitaria e di protezione da parte dei vaccini antinfluenzali in soggetti anziani. 100
Effects of repeated annual influenza vaccination on antibody responses against unchanged vaccine antigens in elderly frail institutionalized volunteers. 99
An influenza outbreak in elderly vaccinated people in the winter season 2007/2008 99
Influenza vaccine induced antibody response against B influenza viruses included in the vaccine or naturally circulating during the winter season 2010/2011 98
Induction of cross-reactive antibodies to 2009 pandemic H1N1 influenza virus (pH1N1) after seasonal vaccination (winters 2003/04 and 2007/08). 96
Comparative study on immunogenicity among split, intradermal and MF59-adjuvanted influenza vaccines in elderly institutionalized subjects 96
Role of nucleocapsid protein antigen detection for safe end of isolation of sars-cov-2 infected patients with long persistence of viral rna in respiratory samples 96
Delivery in asymptomatic Italian woman with SARS-CoV-2 infection 95
Immunogenicity of conventional trivalent inactivated influenza vaccines in pre-vaccination unprotected elderly volunteers in five winters seasons. 92
Comparative study of immunogenicity of split, intradermal and MF59-adjuvanted influenza vaccines in elderly institutionalized subjects 92
Drugs for Influenza Treatment: Is There Significant News? 92
First detection of a reassortant G3P[8] rotavirus Astrain in Italy: a case report in an 8-year-old child 90
The effect of influenza vaccination in patients on long-term oral anticoagulant therapy 89
L’influenza in Umbria nell’inverno 2005/06 89
Vaccination against paediatric respiratory pathogens 89
Immunization with adjuvanted and non-adjuvanted influenza vaccines of HIV-1 positive patients treated with highly active antiretroviral therapy (HAART) 87
Pro-inflammatory cytokines/ chemokines production after infection of A549 Human epithelial cell line with different strains of human influenza viruses 87
UN MAGGIORE UTILIZZO DI SIERI UMANI PUO’ CONTRIBUIRE AD UNA MIGLIORE CARATTERIZZAZIONE ANTIGENICA DEI VIRUS INFLUENZALI PER LA SCELTA DELLE COMPONENTI VACCINALI 87
Multiplex platforms for the identification of respiratory pathogens: Are they useful in pediatric clinical practice? 86
Group a rotavirus surveillance before vaccine introduction in italy, september 2014 to august 2017 85
Pandemic Influenza A/H1N1pdm in Italy: Age, Risk and Population Susceptibility 85
SARS-CoV-2 in semen: a multicenter prospective study and literature review 84
Hospitalization associated with 2009 pandemic influenza A(H1N1) infection in Umbria, a region of central Italy, July – December 2009. 84
MF-59-adjuvanted influenza vaccine: immunogenicity and protection in adult and enderly volunteers (winter season 2003/04). 84
Co-circulation of SARS-CoV-2 Alpha and Gamma variants in Italy, February and March 2021 84
Impaired neutralizing antibody efficacy of tixagevimab-cilgavimab 150+150 mg as pre-exposure prophylaxis against Omicron BA.5. A real-world experience in booster vaccinated immunocompromised patients 84
Influenza vaccine induction of cross–reactive antibodies against different B/Yamagata and B/Victoria-like influenza viruses. , 83
null 83
Cross-reactive antibodies to viruses of both B/Victoria and B/Yamagata lineages as induced by influenza vaccination in middle-aged and elderly volunteers 82
The intersubunit region of influenza virus haemagglutinin as a peptide vaccine candidate. 81
Twenty-seven years experience with immunogenicity of inactivated influenza vaccines in the elderly 81
Hospital‐acquired rotavirus acute gastroenteritis in 10 consecutive seasons in Umbria (Italy) 81
Platelets from COVID-19 Patients Show an Altered Nitric Oxide/Reactive Oxygen Species Production Balance 80
Monitoring of indoor bioaerosol for the detection of SARS-CoV-2 in different hospital settings 80
Induction of Cross-Reactive Antibodies to 2009 Pandemic H1N1 Influenza Virus (pH1N1) After Seasonal Vaccination (Winters 2003/04 and 2007/08) 80
Influenza vaccination and vitamin K antagonist treatment: a placebo-controlled, randomized, double-blind crossover study. 80
Immediate reinfection with Omicron variant after clearance of a previous SARS-CoV-2 infection 79
Declined antibody response following influenza vaccination in elderly as compared with middle-aged volunteers: effects of aging and/or original antigenic sin? 79
Immunogenicity of the MF-59-adjuvanted vaccine in volunteers of different group of age. 79
Tracking the progressive spread of the SARS-CoV-2 Omicron variant in Italy, December 2021 to January 2022 78
Case report: Coxiella burnetii endocarditis in the absence of evident exposure 76
Flow cytometric analysis of intracellular antigen-specific interferon-gamma in human NK and T populations after influenza vaccination 76
Detection of Unusual G6 Rotavirus Strains in Italian Children With Diarrhoea During the 2011 Surveillance Season 76
VALUTAZIONE DELL’EFFICACIA PROTETTIVA E DELLA CAPACITA’ DI INDURRE ANTICORPI CROSS-REATTIVI NEI CONFRONTI DI VIRUS INFLUENZALI DI TIPO B APPARTENENTI AI LINEAGGI YAMAGATA E VICTORIA DA PARTE DI DUE VACCINI INFLUENZALI TRIVALENTI (FLUAD® E INTANZA®) IN ANZIANI ISTITUZIONALIZZATI 76
Partial Protection Induced by 2011–2012 Influenza Vaccine Against Serologically Evidenced A(H3N2) Influenza Virus Infections in Elderly Institutionalized People 76
Induzione di anticorpi omologhi e cross-reattivi nei confronti di virus influenzali di tipo B da parte del vaccino influenzale nell'inverno 2003/2004 73
Seroprevalence against pandemic influenza A(H1N1) 2009 after the first season of circulation in Italy 73
Serological methods are able to determine how well influenza vaccines work 73
Design and validation of a self-administered questionnaire to assess knowledge, attitudes and behaviours about Zika virus infection among general population in Italy. A pilot study conducted among Italian residents in public health 73
Uncommon G9P[4] group A rotavirus strains causing dehydrating diarrhea in young children in Italy 71
L'influenza: sistemi di sorveglianza e campagne vaccinali 71
Serologically diagnosed influenza virus A/California/7/04 (H3N2)infection in people immunised with A/Fujan/411/2002(H3N2)antigen during the 2004/05 winter season 71
Sorveglianza delle paralisi flaccide acute nella regione Umbria 69
Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021 68
Factors influencing humoral immune response after influenza vaccination in elderly and very elderly subjects 68
Effect of age on serum heterologous antibody response elicited by inactivated influenza virus vaccine 67
Increased immunogenicity of an adjuvanted influenza vaccine compared with a conventional subunit vaccine in non-elderly adult HIV seropositive individuals, treated with HAART 67
Intradermal and intramuscular 2011-2012 influenza vaccination of elderly institutionalized volunteers: induction of antibody responses against vaccine and epidemic influenza virus strains 67
Vaccinazione antinfluenzale in soggetti HIV-1 positivi trattati con HAART: influenza sulla risposta anticorpale della concentrazione plasmatici di HIV-1 RNA e del numero di CD4+ 66
Inhibitor development in mild/moderate haemophilia: could influenza vaccination have been the trigger? 66
Influenza viruses and cross-reactivity in healthy adults: humoral and cellular immunity induced by seasonal 2007/2008 influenza vaccination against vaccine antigens and 2009 A(H1N1) pandemic influenza virus 66
Co-circulation of the two influenza B lineages during 13 consecutive influenza surveillance seasons in Italy, 2004-2017 66
Hospital discharges-based search of acute flaccid paralysis cases 2007-2016 in Italy and comparison with the National Surveillance System for monitoring the risk of polio reintroduction 65
Sorveglianza molecolare delle gastroenteriti da rotavirus in Umbria 65
Unexpected spreading of G12P[8] rotavirus strains among young children in a small area of central Italy 64
Measles immunity in healthcare workers of an Italian hospital 64
Diagnosis of infection by SARS-COV-2: Is one molecular test enough? 64
SARS-CoV-2 Molecular Evolution: A Focus on Omicron Variants in Umbria, Italy 63
Immunogenicity of the MF-59-adjuvanted influenza vaccine in volunteers of different groups of age 63
Totale 9.162
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.113
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.113
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021304 0 0 0 0 0 0 0 0 0 0 0 304
2021/2022825 17 152 6 21 31 16 7 308 15 14 103 135
2022/20231.622 119 176 14 144 125 181 3 83 694 5 54 24
2023/2024766 70 67 40 15 7 4 183 33 114 20 121 92
2024/20251.964 25 195 58 87 308 91 97 86 361 142 317 197
2025/20264.086 258 256 217 509 531 382 710 219 466 332 157 49
Totale 11.145